JPWO2020160121A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020160121A5 JPWO2020160121A5 JP2021544320A JP2021544320A JPWO2020160121A5 JP WO2020160121 A5 JPWO2020160121 A5 JP WO2020160121A5 JP 2021544320 A JP2021544320 A JP 2021544320A JP 2021544320 A JP2021544320 A JP 2021544320A JP WO2020160121 A5 JPWO2020160121 A5 JP WO2020160121A5
- Authority
- JP
- Japan
- Prior art keywords
- mir
- oligonucleotide
- nucleic acid
- pharmaceutical composition
- capsid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962798048P | 2019-01-29 | 2019-01-29 | |
| US62/798,048 | 2019-01-29 | ||
| PCT/US2020/015638 WO2020160121A1 (en) | 2019-01-29 | 2020-01-29 | Oligonucleotides and methods for the treatment of age-related macular degeneration |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523320A JP2022523320A (ja) | 2022-04-22 |
| JP2022523320A5 JP2022523320A5 (https=) | 2023-02-06 |
| JPWO2020160121A5 true JPWO2020160121A5 (https=) | 2023-02-06 |
Family
ID=71840609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544320A Pending JP2022523320A (ja) | 2019-01-29 | 2020-01-29 | 加齢黄斑変性の処置のためのオリゴヌクレオチドおよび方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220195428A1 (https=) |
| EP (1) | EP3918072A4 (https=) |
| JP (1) | JP2022523320A (https=) |
| WO (1) | WO2020160121A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2022230987A1 (https=) * | 2021-04-30 | 2022-11-03 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7517864B2 (en) * | 2001-05-18 | 2009-04-14 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| US7683036B2 (en) * | 2003-07-31 | 2010-03-23 | Regulus Therapeutics Inc. | Oligomeric compounds and compositions for use in modulation of small non-coding RNAs |
| EP1791567B1 (en) * | 2004-08-10 | 2015-07-29 | Alnylam Pharmaceuticals Inc. | Chemically modified oligonucleotides |
| CA2577519A1 (en) * | 2004-08-23 | 2006-03-30 | Nucleonics, Inc. | Multiple rna polymerase iii promoter expression constructs |
| US20110130440A1 (en) * | 2008-03-26 | 2011-06-02 | Alnylam Pharmaceuticals, Inc. | Non-natural ribonucleotides, and methods of use thereof |
| US8057295B2 (en) * | 2008-11-10 | 2011-11-15 | Wms Gaming Inc. | Wagering game having award group selection feature |
| US20110281933A1 (en) * | 2010-05-13 | 2011-11-17 | Saint Louis University | Methods and compositions for the management of cardiovascular disease with oligonucleotides |
| US20120053227A1 (en) * | 2010-08-27 | 2012-03-01 | New York University | miR-33 INHIBITORS AND USES THEREOF |
| US9241950B2 (en) * | 2011-04-28 | 2016-01-26 | New York University | MiR-33 inhibitors and uses thereof to decrease inflammation |
| US20120301439A1 (en) * | 2011-05-24 | 2012-11-29 | Washington University | Inhibition of choroidal neovascularization |
| US20140363469A1 (en) * | 2012-01-19 | 2014-12-11 | Alnylam Pharmaceuticals, Inc. | Viral attenuation and vaccine production |
| US11046955B2 (en) * | 2015-04-24 | 2021-06-29 | University Of Massachusetts | Modified AAV constructs and uses thereof |
| GB201607797D0 (en) * | 2016-05-04 | 2016-06-15 | Provost Fellows & Scholars College Of The Holy Undivided Trinity Of Queen Elizabeth Near Dublin | Glaucoma therapy |
| US10426817B2 (en) * | 2017-01-24 | 2019-10-01 | Macregen, Inc. | Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimetics |
-
2020
- 2020-01-29 EP EP20748388.4A patent/EP3918072A4/en active Pending
- 2020-01-29 JP JP2021544320A patent/JP2022523320A/ja active Pending
- 2020-01-29 US US17/310,235 patent/US20220195428A1/en active Pending
- 2020-01-29 WO PCT/US2020/015638 patent/WO2020160121A1/en not_active Ceased